« Ohio Gov delays multiple executions while denying clemency for double murderer slated to die later this month | Main | "The Racial Politics of Mass Incarceration" »

September 3, 2017

A long-weekend review of some marijuana reform news and notes

A long weekend seems to provide a good excuse to review some recent posts of note from Marijuana Law, Policy & Reform. So here goes:

September 3, 2017 at 08:48 PM | Permalink

Comments

Lawyer paradise. The conflict of laws in all directions is total job security. Criminal, regulatory, employment, property, disability, health.

Posted by: David Behar | Sep 3, 2017 9:55:08 PM

Overdose deaths from cocaine and from methamphetamine are soaring. Most prescription overdoses also involve heroin and carfentanyl.

Those facts imply that the overdose epidemic is not specific to opiates. The accelerated rates began in 2015.

This lack of specificity supports the theory that the Ferguson Effect is a factor in the epidemic of overdose deaths.

That means that Rod Rosenstein must be held to account, not just for 100's of excessive murders in Baltimore, but also for 10000's of excessive overdose deaths. This Harvard Law moron may be a mass murderer on an unprecedented scale, around the nation.

Posted by: David Behar | Sep 4, 2017 3:49:52 PM

As to road fatalities on marijuana.

I do not have a name for this form of bias. It is to use a rare flaw to condemn the entire activity. The Small Imperfection Bias. My conclusion is that we should stop driving until crashes are ended. It fails to state confounding factors, such as an increase in driving from the economic recovery, the aggressive personalities of the crash victims, increased by the decarceration trend, and increases in population, decline of roads conditions. It fails to provide balancing benefits. It is a form of false propaganda, and deceptive.

Celebrex, a pain medicine raised the low rate of heart attacks by 4 times, and was pulled off the market by its company, for fear of litigation. The FDA did not even ask it be pulled off the market. It just issued a Black Box Warning. The care of millions of people with pain and arthritis was disrupted. The protective effect of Celebrex to prevent colon cancer was stopped. It was replaced by alternatives with high rates of stomach bleeding. The FDA even asked that it be returned to the market.

This bias is commonly used by advocates, attacking flaws that are rare and marginal.

Posted by: David Behar | Sep 5, 2017 7:45:43 AM

Post a comment

In the body of your email, please indicate if you are a professor, student, prosecutor, defense attorney, etc. so I can gain a sense of who is reading my blog. Thank you, DAB